High-dose corticoid therapy in Hodgkin's disease and other lymphomas.
D000293:Adolescent; D000328:Adult; D000368:Aged; D003348:Cortisone / Q000008:administration & dosage* / Q000009:adverse effects; D003920:Diabetes Mellitus / Q000139:chemically induced; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D007239:Infections / Q000209:etiology; D008223:Lymphoma / Q000188:drug therapy*; D008224:Lymphoma, Follicular / Q000188:drug therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D001523:Mental Disorders / Q000209:etiology; D008775:Methylprednisolone / Q000008:administration & dosage* / Q000009:adverse effects; D008875:Middle Aged; D011239:Prednisolone / Q000008:administration & dosage* / Q000009:adverse effects; D011241:Prednisone / Q000009:adverse effects
D011239:Prednisolone; D003348:Cortisone; D011241:Prednisone; D008775:Methylprednisolone